Nahila Justo

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.

Journal: Infectious diseases and therapy

Published: January 15, 2026

Medical Absenteeism and Premature Death in Spinal Muscular Atrophy in Sweden: A Population-Based Matched Register Study of People of Working Age.

Medical Absenteeism and Premature Death in Spinal Muscular Atrophy in Sweden: A Population-Based Matched Register Study of People of Working Age.

Journal: Advances in therapy

Published: May 27, 2025

Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study.

Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study.

Journal: The Journal of infection

Published: October 29, 2024

Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].

Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].

Journal: The Lancet regional health. Europe

Published: August 19, 2024

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.

Journal: The Lancet regional health. Europe

Published: July 10, 2023

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden.

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: June 01, 2023

Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden.

Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden.

Journal: Clinical drug investigation

Published: May 29, 2023

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain.

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain.

Journal: BMC health services research

Published: April 16, 2023

Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction.

Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction.

Journal: Journal of clinical medicine

Published: January 25, 2023

Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain.

Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain.

Journal: BMC health services research

Published: July 27, 2022

Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain.

Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain.

Journal: Journal of clinical medicine

Published: June 29, 2022

Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?

Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?

Journal: PloS one

Published: June 20, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026